Akcea Therapeutics Inc (AKCA) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:AKCA

18.17
+0.03 (+0.17%)
At close: Oct 9, 2020
18.15
-0.02 (-0.11%)
After Hours: 10/9/2020, 8:24:15 PM
Buy % Consensus

60

ChartMill assigns a Buy % Consensus number of 60% to AKCA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • AKCA was analyzed by 3 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about AKCA.
  • In the last month the buy percentage fell by 10 points. So the trust of analysts is decreasing.
  • Only 3 analysts analyzed AKCA. So this is just the average opinion of a couple of analysts.

Related screens

AKCA Historical Analyst RatingsAKCA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -21 -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 1 2 3 4
AKCA Current Analyst RatingAKCA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades

Akcea Therapeutics Inc / AKCA FAQ

Can you provide the consensus rating for Akcea Therapeutics Inc stock?

The consensus rating for Akcea Therapeutics Inc (AKCA) is 60 / 100 . This indicates that analysts generally have a neutral outlook on the stock.


What is the number of analysts for AKCA stock?

The number of analysts covering Akcea Therapeutics Inc (AKCA) is 3.